Community intervention of a single-dose or 2-dose regimen of bivalent human papillomavirus vaccine in schoolgirls in Thailand: vaccine effectiveness 2 years and 4 years after vaccination

Our study demonstrated that both single-dose and 2-dose HPV vaccination significantly decreased HPV-16/18 point prevalence 2 years and 4 years after vaccination. Crude vaccine effectiveness at 4 years after vaccination was greater than 90% for both the single-dose and 2-dose regimens; the single-dose regimen was not inferior to the 2-dose regimen. These data show that a single dose of HPV vaccine provides high levels of protection when administered to schoolgirls younger than 15 years of age.

Authors

Institutions

Publication Details

Journal
JNCI Monographs
Published
2024-10-01
DOI
https://doi.org/10.1093/jncimonographs/lgae036
Citations
1
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Community intervention of a single-dose or 2-dose regimen of bivalent human papillomavirus vaccine in schoolgirls in Thailand: vaccine effectiveness 2 years and 4 years after vaccination

Sunju Park, Pornjarim Nilyanimit, Suchada Jiamsiri, Worrawan Klinsupa et al.
1 citations
JNCI Monographs
Cervical Cancer and HPV Research
0.39
article

Community intervention of a single-dose or 2-dose regimen of bivalent human papillomavirus vaccine in schoolgirls in Thailand: vaccine effectiveness 2 years and 4 years after vaccination

Sunju Park, Pornjarim Nilyanimit, Suchada Jiamsiri, Worrawan Klinsupa, Jinae Lee, Sompong Vongpunsawad, Hyeong-Won Seo, Chawetsan Namwat, Lauri E. Markowitz, Jean‐Louis Excler, Yun Chon, Julia Lynch, Joshua N. Sampson, Elizabeth R. Unger, Patummal Silaporn, Chulwoo Rhee, Nakorn Premsri, Gitika Panicker, Nimesh Poudyal, Deok-Ryun Kim, Hyeon Seon Ahn, Yong Poovorawan, Supachai Rerks‐Ngarm
article en
1 citations

Abstract

Our study demonstrated that both single-dose and 2-dose HPV vaccination significantly decreased HPV-16/18 point prevalence 2 years and 4 years after vaccination. Crude vaccine effectiveness at 4 years after vaccination was greater than 90% for both the single-dose and 2-dose regimens; the single-dose regimen was not inferior to the 2-dose regimen. These data show that a single dose of HPV vaccine provides high levels of protection when administered to schoolgirls younger than 15 years of age.

JNCI MonographsVol. 2024(67)
Centers for Disease Control and Prevention (US), National Institutes of Health (US), International Vaccine Institute (KR), Chulalongkorn University (TH), National Cancer Institute (US)
Bill and Melinda Gates Foundation
Good health and well-being
Openalex Percentile: Top 32%
Cervical Cancer and HPV Research
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.